| Authors: |
Hendricks JA; Discovery Sciences, AstraZeneca, Boston, Massachusetts 02451, United States., Beaton N; Biognosys AG, Wagistrasse 21, Schlieren 8952, Switzerland., Chernobrovkin A; Pelago Bioscience AB, Banvaktsvägen 20, Solna 17148, Sweden., Miele E; Discovery Sciences, AstraZeneca, Boston, Massachusetts 02451, United States., Hamza GM; Discovery Sciences, AstraZeneca, Boston, Massachusetts 02451, United States.; Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire 03824, United States., Ricchiuto P; Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, U.K., Tomlinson RC; Discovery Sciences, AstraZeneca, Boston, Massachusetts 02451, United States., Friman T; Pelago Bioscience AB, Banvaktsvägen 20, Solna 17148, Sweden., Borenstain C; Discovery Sciences, AstraZeneca, Boston, Massachusetts 02451, United States., Barlaam B; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hande S; Oncology R&D, Boston, Massachusetts 02451, United States., Lamb ML; Oncology R&D, Boston, Massachusetts 02451, United States., De Savi C; Oncology R&D, Boston, Massachusetts 02451, United States., Davies R; Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, U.K., Main M; Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, U.K., Hellner J; Pelago Bioscience AB, Banvaktsvägen 20, Solna 17148, Sweden., Beeler K; Biognosys AG, Wagistrasse 21, Schlieren 8952, Switzerland., Feng Y; Biognosys AG, Wagistrasse 21, Schlieren 8952, Switzerland., Bruderer R; Biognosys AG, Wagistrasse 21, Schlieren 8952, Switzerland., Reiter L; Biognosys AG, Wagistrasse 21, Schlieren 8952, Switzerland., Molina DM; Pelago Bioscience AB, Banvaktsvägen 20, Solna 17148, Sweden., Castaldi MP; Discovery Sciences, AstraZeneca, Boston, Massachusetts 02451, United States. |
